Ma, A.; Biersack, B.; Goehringer, N.; Nitzsche, B.; Höpfner, M.
Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma. J. Pers. Med. 2022, 12, 738.
https://doi.org/10.3390/jpm12050738
AMA Style
Ma A, Biersack B, Goehringer N, Nitzsche B, Höpfner M.
Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma. Journal of Personalized Medicine. 2022; 12(5):738.
https://doi.org/10.3390/jpm12050738
Chicago/Turabian Style
Ma, Andi, Bernhard Biersack, Nils Goehringer, Bianca Nitzsche, and Michael Höpfner.
2022. "Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma" Journal of Personalized Medicine 12, no. 5: 738.
https://doi.org/10.3390/jpm12050738
APA Style
Ma, A., Biersack, B., Goehringer, N., Nitzsche, B., & Höpfner, M.
(2022). Novel Thienyl-Based Tyrosine Kinase Inhibitors for the Treatment of Hepatocellular Carcinoma. Journal of Personalized Medicine, 12(5), 738.
https://doi.org/10.3390/jpm12050738